Transcriptional Isoforms of NAD+ kinase regulate oxidative stress resistance and melanoma metastasis

Graciela Cascio1, Kelsey N Aguirre1, Kellsey P Church1

  • 1Sandra and Edward Meyer Cancer Center, 413 East 69th Street, Belfer Research Building, Weill Cornell Medicine, 10021, New York, NY, USA.

Redox Biology
|August 21, 2024
PubMed

Insights

Metastatic melanoma cells increase antioxidant capacity via NAD+ kinase (NADK) Isoform 3. This isoform enhances oxidative stress resistance and promotes cancer metastasis, offering a potential therapeutic target.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Metastasizing cancer cells face oxidative stress, necessitating metabolic adaptations for survival.
  • Nicotinamide adenine dinucleotide phosphate (NADPH) is crucial for antioxidant regeneration and plays a role in metastasis.
  • Metastatic melanoma cells exhibit elevated NADPH and NADP+ levels, indicating increased de novo NADP+ biosynthesis.

Purpose of the Study:

  • To investigate the role of NAD+ kinase (NADK) isoforms in metastatic melanoma.
  • To determine the specific NADK isoform responsible for increased NADP+ biosynthesis and its impact on metastasis.

Main Methods:

  • Differential expression analysis of NADK isoforms in metastatic melanoma cells.
  • Functional assays to assess the impact of NADK isoforms on NADP(H) pools, oxidative stress resistance, and metastatic colonization.
  • Investigating the transcriptional regulation of NADK Isoform 3 by oxidative stress and NRF2.

Main Results:

  • NAD+ kinase (NADK) Isoform 3 is specifically upregulated in metastatic melanoma cells.
  • NADK Isoform 3 is more effective than Isoform 1 in expanding NADP(H) pools and enhancing oxidative stress resistance.
  • Oxidative stress upregulates NADK Isoform 3 transcriptionally via NRF2, promoting metastatic colonization.

Conclusions:

  • NADK isoforms play a previously unrecognized role in oxidative stress resistance and cancer metastasis.
  • NADK Isoform 3 is a key mediator of metastatic melanoma cell adaptation and progression.
  • NADK Isoform 3 represents a promising therapeutic target for metastatic melanoma.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K